PD-MitoQUANT PIs Drs. Olga Corti, Stéphane Hunot (both based at the ICM) and Luc Bousset (Centre National de la Recherche Scientifique (CNRS)) are on the organizing committee of the 2nd “pHysiopathology of Parkinson’s DisEase” (HOPE) conference taking place at the Institut du Cerveau et de la Moelle Epinière (ICM) in Paris from the 29th -31st January 2020.
Following the success of the first meeting and the positive feedback from participants regarding the latest scientific advances and the integration of basic research into clinical research, ICM is pleased to invite researchers to take part in this second edition.
Topics include the epigenetic and genetic determinants of Parkinson’s disease, their molecular mechanisms and their modelling, in order to better understand the pathophysiology of Parkinson’s disease and open pre-clinical, clinical and imaging perspectives.
In addition, ICM proposes a workshop the first day on two topics that will be discussed during the congress: “Cellular modelling using microfluidic and stem cell technologies”, and “Available imaging tools for cellular models and to humans”
Register on the conference website: https://hope2020.
Registration deadline: January 12, 2020.
PD-MitoQUANT has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821522. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.
The material presented and views expressed here reflect the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.